This Week in Science

In the letters section of Science, Oxford researchers discuss the future of releasing DNA data. They say that the one-month delay to access the data is worth the wait. "But it is not just scientists' concerns that should be addressed; it is potential concerns of individuals participating in research projects and the maintenance of public trust. If it really transpires that fears are exaggerated, then open access could be resumed," they write.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.

A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.

The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."

In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.